C12N 2830/003
Tet inducible
Official title: tet inducible
C12N2830/003 (Tet inducible) appears on 189 US grants and 386 published applications in this corpus.
Search patents in C12N- Granted patents
- 189
- Published applications
- 386
- Assignees
- 215
- Inventors
- 798
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 5 |
| 2002 | 7 | 14 |
| 2003 | 5 | 18 |
| 2004 | 2 | 20 |
| 2005 | 2 | 16 |
| 2006 | 4 | 13 |
| 2007 | 6 | 11 |
| 2008 | 1 | 14 |
| 2009 | 9 | 8 |
| 2010 | 6 | 20 |
| 2011 | 7 | 12 |
| 2012 | 5 | 6 |
| 2013 | 7 | 13 |
| 2014 | 9 | 5 |
| 2015 | 14 | 15 |
| 2016 | 7 | 13 |
| 2017 | 9 | 12 |
| 2018 | 9 | 7 |
| 2019 | 5 | 18 |
| 2020 | 5 | 12 |
| 2021 | 8 | 19 |
| 2022 | 5 | 19 |
| 2023 | 11 | 19 |
| 2024 | 5 | 26 |
| 2025 | 12 | 33 |
| 2026 | 6 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered phagocytes, and related compositions, vectors, methods and systems22 Sep 2026US 12,741,025 B2The Regents of the University of California
- Protein heterodimer and use thereof18 Aug 2026US 12,709,638 B2Ningbo Innovative Mechanism Bioscience LLC
- Phosphate sensing microbial gene switch9 Jun 2026US 12,649,699 B2Switch Bioworks, Inc.
- DNA construct for diagnosing and treating cancer26 May 2026US 12,637,688 B2
- Mutant reverse tetracycline transactivators for expression of genes12 May 2026US 12,624,362 B2President and Fellows of Harvard College
- Recombinant expression vector for catalase secretion and escherichia coli strain transformed therewith8 Oct 2026US 2026/0308603 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Programmable rna scaffolds for multivariate effector recruitment using crispr/cas24 Sep 2026US 2026/0286352 A1William Marsh Rice University
- Methods for generating artificial thymus, products and uses thereof17 Sep 2026US 2026/0275290 A1
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
- Mutant reverse tetracycline transactivators for expression of genes30 Jul 2026US 2026/0218208 A1President and Fellows of Harvard College
Most cited
By later US patents
- Methods for regulating gene expression170US 5,814,618 ABASF SE · 1998
- Compositions and methods for helper-free production of recombinant adeno-associated viruses159US 6,953,690 B1The Trustees of the University of Pennsylvania · 2005
- Methods using cre-lox for production of recombinant adeno-associated viruses111US 6,274,354 B1The Trustees of the University of Pennsylvania · 2001
- Gene regulation in transgenic animals using a transposon-based vector105US 7,608,451 B2Board of Supervisors of Louisiana State University Mechanical College · 2009
- Tetracycline regulated transcriptional modulators with altered DNA binding specificities102US 5,589,362 ABASF SE · 1996